4Richter S, Duray G, Gronefeld G, et al. Prevention of sudden cardiac death: lessons from recent controlled trials[J]. Circ J, 2005, 69(6):625- 629.
5The American Heart Association in Collaboration with the In ternational Liaison Committee on Resuscitation. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular Care. Part 6: advanced cardiovascular life support: section 5: pharmacology I: agents for arrhythmias[J]. Circulation, 2000, 102(8 Suppl):112- 128.
6Gury C, Canceil O, Iaria P. Antipsychotic drugs and cardiovascular safety:current studies of prolonged Q T interval and risk of ventricular arrhythmia[J]. Encephale, 2002, 26 (6) : 62 -72.
7Mortl D, Agneter E, Krivanek P, et al. Dual rate-dependent cardiac electrophysiologic effects of haloperidol: slowing of intraventricular conduction and lengthening of repolarization[J]. J Cardiovasc Pharmacol, 2003,41 ( 6 ) : 870-879.
8Adamantidism M, Kerram P, Caron JF, et al. Droperidol Exert dual effects on repolarization and induces early afterde polarization and triggered activity in rabbit Purkinje fibers [J]. J Pharmacol Exp Ther, 1993, 266(2):884- 893.
